Article

Star Tribune on 2021-11-22 23:15

Concerns grow over safety of Alzheimer's drug Aduhelm after death of patient who got the drug

Follow the StarTribune for the news, photos and videos from the Twin Cities and beyond.

Related news

Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug The New York Times
FDA approves new Alzheimer's drug, Aduhelm, the first in nearly two decades USA today
Biogen cutting cost of Alzheimer's drug Arkansas Online
Japan , Cambridge
FFDA approval of Alzheimer's drug Aduhelm 'rife with irregularities,' House report says foxbusiness.com
FDA remains upbeat on Alzheimer's drug nwaonline.com
Wall Street , Cambridge
Biogen shares soar as FDA reviewers support Alzheimer's drug Sydney Morning Herald
Wall Street , Massachusetts , Cambridge
"It's like watching a child" - Wife of Alzheimer's patient in desperate plea as Brexit set to delay new drug The Daily Record
Europe , Americas , San Francisco , Canada , Scotland
Alzheimer's drug draws mixed reviews nwaonline.com
Japan , Cambridge , Mayo Clinic , San Diego , Flagg
New Alzheimer's drug approved in U.S. despite concerns about effectiveness CBC
Providence , Phoenix , Japan
Biogen cuts the price tag on its Alzheimer's drug in half - Mon, 20 Dec 2021 PST apnews.com
Massachusetts , Cambridge , Japan
Alzheimer's Drug Aduhelm Faces Crucial Medicare Decision The New York Times
Medicare Won’t Pay For Controversial Alzheimer’s Drug Aduhelm Without A New Trial Forbes
Cambridge
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm WRAL
United States , Switzerland
Alzheimer's drug rollout off to slow start Arkansas Online
Wall Street , Cambridge
Change at the top for Biogen after Alzheimer's drug flops - Tue, 03 May 2022 PST apnews.com
Europe , Wall Street , Cambridge
BBiogen Is Still a Buy Despite Alzheimer's Drug Concerns, Analyst Says2 min read barrons.com
BAcknowledging Concerns Over Biogen's Alzheimer's Drug, FDA Asks for Investigation2 min read barrons.com